Applied DNA Sciences has partnered with Colorcon to commercialize product authentication technology for pharmaceutical and nutraceutical industries.
Under the technology license memorandum of understanding (MOU), Applied DNA’s molecular taggant and authentication technology will be integrated with Colorcon’s portfolio of film coating, ink and color dispersion solutions for use in solid oral dosage forms in the pharmaceutical and nutraceutical industries.
The created platform will help to decrease the risks associated with counterfeit and falsified medications entering the drug supply chain.
Serialization of packaging will help to reduce the risks associated with counterfeit drugs, while the deployment of multiple technologies will further secure supply chain integrity.
Colorcon film coating GM Kelly Boyer said: “By incorporating molecular taggants from Applied DNA into our specialty excipients, Colorcon is able to offer a simple and seamless solution to our pharmaceutical and nutraceutical customers to address counterfeiting and product diversion issues.”
Applied DNA CEO and president James Hayward said: “This MOU is the culmination of a multi-year effort to extend the applicability of our molecular taggant technology to an industry whose participants are moving quickly to address supply chain concerns and comply with federal serialization mandates across multiple continents.”
Colorcon is engaged in the development and distribution of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry.
Applied DNA offers molecular technologies, which enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics.
The company’s DNA-based CertainT platform will help to identify, tag, test and track products.